NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Dicerna Pharmaceuticals 

790 Memorial Drive
Suite 104
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-621-8097 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference 9/21/2009 9:01:11 AM    More...
Dicerna Pharmaceuticals to Present at Upcoming Conferences 9/2/2009 9:13:03 AM    More...
Dicerna Pharmaceuticals Scientific Founder to Present Data Demonstrating Dual Inhibitory Function of Aptamer-Dicer Substrate siRNA Conjugates at Oligonucleotide Therapeutics Conference 8/3/2009 9:29:35 AM    More...
Archemix Corporation and Dicerna Pharmaceuticals to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics 7/21/2009 6:53:02 AM    More...
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board 7/8/2009 8:52:59 AM    More...
Dicerna Pharmaceuticals to Present at Upcoming RNAi-Focused Scientific Conferences 6/4/2009 9:00:19 AM    More...
Dicerna Pharmaceuticals to Present at Upcoming Conferences 5/13/2009 9:24:43 AM    More...
Dicerna Pharmaceuticals to Present at the Second Annual Biotechnology Industry Organization (BIO) National Venture Conference 3/24/2009 9:23:03 AM    More...
Dicerna Pharmaceuticals Secures Exclusive Worldwide Right to Sublicense the Dicer Substrate Technology RNAi Platform 3/18/2009 7:33:06 AM    More...
Dicerna Pharmaceuticals Appoints C. Ronald Kahn, M.D., Vice Chairman of Joslin Diabetes Center, to its Scientific Advisory Board 1/29/2009 9:24:29 AM    More...
123